"My clinical work is through the neuropsychological consultation service which provides neurocognitive evaluations for patients experiencing brain tumors, leukemia, genetic disorders and rare diseases, seizure disorders, heart transplantation and heart failure, concussion, cerebral palsy, neurofibromatosis, psychological/psychiatric disorders, and many other diseases and disorders. I enjoy working with these children and their families immensely and feel honored to be part of their journey as they navigate a new diagnosis, enter treatment, and on their path to recovery."

Dr. Bledsoe received his Ph.D. in Clinical Psychology at Michigan State University. After graduate school he completed his clinical residency and two year postdoctoral training in neuropsychology at the University of Washington School of Medicine and Seattle Childrens Hospital. He is currently an assistant professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine and pediatric neuropsychologist in the Department of Psychiatry and Behavioral Medicine at Seattle Childrens Hospital. Dr. Bledsoe also conducts research on neurocognitive impacts of treatment for pediatric cancer as a principal investigator through the Center for Child Health, Behavior, and Development (CCHBD) at Seattle Childrens Hospital Research Institute.

Social functioning using direct and indirect measures with children with High Functioning Autism, nonverbal learning disability, and typically developing children.25711370 Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence, 2016 : 22(3)318-35

Gender differences in brain activation on a mental rotation task.22651549 The International journal of neuroscience, 2012 Oct. : 122(10)590-7

Bledsoe JC, Semrud-Clikeman M, Pliszka SR

Neuroanatomical and neuropsychological correlates of the cerebellum in children with attention-deficit/hyperactivity disorder--combined type.21621143 Journal of the American Academy of Child and Adolescent Psychiatry, 2011 June : 50(6)593-601 PMCID:PMC3104210

Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor

St. Baldrick's Foundation

Cortical Thickness and Morphology in Children with ADHD-Combined Subtype: Effects of Medication Treatment and Implications for Neuropsychological Functioning and Behavior

Blue Cross Blue Shield

Overview

Medical/Professional School

Michigan State University, East Lansing

Residency

Psychology, University of Washington, Seattle

Fellowship

Neuropsychology, Seattle Children's Hospital, Seattle

Clinical Interests

Pediatric brain tumors, leukemia

Research Description

Dr. Bledsoe?s research and training has bridged the fields of multi-modal neuroimaging and neurocognitive development. His current work attempts to better understand the impacts of surgery, radiation, and chemotherapy impact cognitive development in children. He has been fortunate to collaborate on multi-institutional projects assessing cognitive late effects in pediatric brain tumors using diffusion tensor imaging, structural brain imaging, and resting state functional imaging techniques. Dr. Bledsoe is also beginning a longitudinal project that will attempt to correlate neurocognitive changes following radiation therapy with changes in cortical development and white matter integrity. This work will include the team at Seattle Children?s Hospital as well as colleagues at the University of Washington?s Integrative Brain Imaging Center (IBIC) who have expertise in multi-modal imaging and machine learning analysis.

Remote Access

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.